ARTERIOVENOUS FISTULA
Clinical trials for ARTERIOVENOUS FISTULA explained in plain language.
Never miss a new study
Get alerted when new ARTERIOVENOUS FISTULA trials appear
Sign up with your email to follow new studies for ARTERIOVENOUS FISTULA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
No-Scalpel dialysis access: new catheter method could change kidney care
Disease control Recruiting nowThis study tests a new device that creates dialysis access through a small skin puncture instead of open surgery. It involves 126 adults with kidney failure who need dialysis. The goal is to see if the procedure is safe and works well, with participants followed for up to five ye…
Matched conditions: ARTERIOVENOUS FISTULA
Phase: NA • Sponsor: Venova Medical • Aim: Disease control
Last updated May 17, 2026 09:18 UTC
-
New device tested to block blood flow in aneurysms and other conditions
Disease control Recruiting nowThis study is testing a medical device called the Cera Vascular Plug, which is used to block blood flow in blood vessels. It is for people with conditions like aneurysms, abnormal connections between arteries and veins, or bleeding in the spleen. The goal is to confirm the device…
Matched conditions: ARTERIOVENOUS FISTULA
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 09:11 UTC
-
New wrap could save kidney patients from repeated dialysis access surgeries
Disease control Recruiting nowThis study tests a special wrap called SelfWrap placed around blood vessels during fistula creation for dialysis. The goal is to help the fistula mature faster and work without extra procedures. About 600 adults with chronic kidney disease needing a new fistula will take part. Th…
Matched conditions: ARTERIOVENOUS FISTULA
Phase: NA • Sponsor: VenoStent • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Blood thinner may boost dialysis access success in kidney patients
Disease control Recruiting nowThis study tests whether a short course of the blood thinner apixaban can help arteriovenous fistulas mature properly in people with end-stage kidney disease. About 190 adults will receive either apixaban or a placebo around the time of fistula creation surgery. The goal is to se…
Matched conditions: ARTERIOVENOUS FISTULA
Phase: NA • Sponsor: Combined military hospital lahore • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New device aims to make dialysis access easier for kidney patients
Disease control Recruiting nowThis study is testing a device called the BD WavelinQ EndoAVF System, which creates a connection between an artery and a vein (called an AV fistula) in people with kidney failure who need dialysis. The goal is to see if this device helps make dialysis treatments more successful a…
Matched conditions: ARTERIOVENOUS FISTULA
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New liquid embolic agent could improve brain AVM treatment
Disease control Recruiting nowThis study tests a new liquid material that blocks abnormal blood vessels in the brain. About 116 adults with brain arteriovenous malformation (AVM) will receive this treatment or a standard one. The goal is to see if the new liquid is as safe and effective at reducing the size o…
Matched conditions: ARTERIOVENOUS FISTULA
Phase: NA • Sponsor: MicroPort NeuroTech Co., Ltd. • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC
-
One needle instead of two: new dialysis technique could save blood vessels and money
Symptom relief Recruiting nowThis study tests a new way to do dialysis using only one needle in the arm's blood vessel and a second needle in the leg to return cleaned blood. The goal is to reduce damage to the main dialysis blood vessel, lower the risk of complications like scarring and blockages, and cut d…
Matched conditions: ARTERIOVENOUS FISTULA
Phase: NA • Sponsor: Suzhou Municipal Hospital of Anhui Province • Aim: Symptom relief
Last updated May 17, 2026 09:09 UTC